Skip to main content
Erschienen in: Investigational New Drugs 5/2009

01.10.2009 | PRECLINICAL STUDIES

Mixed steroidal tetraoxanes induce apoptotic cell death in tumor cells

verfasst von: Željko Žižak, Zorica Juranić, Dejan Opsenica, Bogdan A. Šolaja

Erschienen in: Investigational New Drugs | Ausgabe 5/2009

Einloggen, um Zugang zu erhalten

Summary

In this study we investigated the antiproliferative activity of six mixed steroidal tetraoxanes against various tumor cell lines, the toxicity against normal peripheral blood mononuclear cells (PBMC), and the mode of HeLa cell death induced by these compounds. Investigated tetraoxanes exerted a dose dependent antiproliferative action at micromolar concentrations toward target tumor cell lines. Treatment of HeLa cells for 24 h with all tetraoxanes induced apoptosis, as confirmed by morphological analysis and by the appearance of a typical ladder pattern in the DNA fragmentation assay.
Literatur
1.
Zurück zum Zitat Vennerstrom JL, Fu HN, Ellis WY, Ager AL Jr, Wood JK, Andersen SL, Gerena L, Milhous WK (1992) Dispiro-1,2,4,5-tetraoxanes: a new class of antimalarial peroxides. J Med Chem 35:3023–3027 doi:10.1021/jm00094a015 PubMedCrossRef Vennerstrom JL, Fu HN, Ellis WY, Ager AL Jr, Wood JK, Andersen SL, Gerena L, Milhous WK (1992) Dispiro-1,2,4,5-tetraoxanes: a new class of antimalarial peroxides. J Med Chem 35:3023–3027 doi:10.​1021/​jm00094a015 PubMedCrossRef
2.
Zurück zum Zitat Todorovic NM, Stefanovic M, Tinant B, Declercq JP, Makler MT, Solaja BA (1996) Steroidal geminal dihydroperoxides and 1,2,4,5-tetraoxanes: structure determination and their antimalarial activity. Steroids 61:688–696 doi:10.1016/S0039-128X(96)00203-6 PubMedCrossRef Todorovic NM, Stefanovic M, Tinant B, Declercq JP, Makler MT, Solaja BA (1996) Steroidal geminal dihydroperoxides and 1,2,4,5-tetraoxanes: structure determination and their antimalarial activity. Steroids 61:688–696 doi:10.​1016/​S0039-128X(96)00203-6 PubMedCrossRef
3.
Zurück zum Zitat Dong Y, Matile H, Chollet J, Kaminsky R, Wood JK, Vennerstrom JL (1999) Synthesis and antimalarial activity of 11 dispiro-1,2,4,5-tetraoxane analogues of WR 148999. 7,8,15,16-Tetraoxadispiro[5.2.5.2]hexadecanes substituted at the 1 and 10 positions with unsaturated and polar functional groups. J Med Chem 42:1477–1480 doi:10.1021/jm980698f PubMedCrossRef Dong Y, Matile H, Chollet J, Kaminsky R, Wood JK, Vennerstrom JL (1999) Synthesis and antimalarial activity of 11 dispiro-1,2,4,5-tetraoxane analogues of WR 148999. 7,8,15,16-Tetraoxadispiro[5.2.5.2]hexadecanes substituted at the 1 and 10 positions with unsaturated and polar functional groups. J Med Chem 42:1477–1480 doi:10.​1021/​jm980698f PubMedCrossRef
4.
Zurück zum Zitat Vennerstrom JL, Dong Y, Andersen SL, Ager AL Jr, Fu H, Miller RE, Wesche DL, Kyle DE, Gerena L, Walters SM, Wood JK, Edwards G, Holme AD, McLean WG, Milhous WK (2000) Synthesis and antimalarial activity of sixteen dispiro-1,2,4, 5-tetraoxanes: alkyl-substituted 7,8,15,16-tetraoxadispiro[5.2.5. 2]hexadecanes. J Med Chem 43:2753–2758 doi:10.1021/jm0000766 PubMedCrossRef Vennerstrom JL, Dong Y, Andersen SL, Ager AL Jr, Fu H, Miller RE, Wesche DL, Kyle DE, Gerena L, Walters SM, Wood JK, Edwards G, Holme AD, McLean WG, Milhous WK (2000) Synthesis and antimalarial activity of sixteen dispiro-1,2,4, 5-tetraoxanes: alkyl-substituted 7,8,15,16-tetraoxadispiro[5.2.5. 2]hexadecanes. J Med Chem 43:2753–2758 doi:10.​1021/​jm0000766 PubMedCrossRef
5.
Zurück zum Zitat Vennerstrom JL, Ager AL Jr, Andersen SL, Grace JM, Wongpanich V, Angerhofer CK, Hu JK, Wesche DL (2000) Assessment of the antimalarial potential of tetraoxane WR 148999. Am J Trop Med Hyg 62:573–578PubMed Vennerstrom JL, Ager AL Jr, Andersen SL, Grace JM, Wongpanich V, Angerhofer CK, Hu JK, Wesche DL (2000) Assessment of the antimalarial potential of tetraoxane WR 148999. Am J Trop Med Hyg 62:573–578PubMed
6.
Zurück zum Zitat Opsenica D, Pocsfalvi G, Juranic Z, Tinant B, Declercq JP, Kyle DE, Milhous WK, Solaja BA (2000) Cholic acid derivatives as 1,2,4,5-tetraoxane carriers: structure and antimalarial and antiproliferative activity. J Med Chem 43:3274–3282 doi:10.1021/jm000952f PubMedCrossRef Opsenica D, Pocsfalvi G, Juranic Z, Tinant B, Declercq JP, Kyle DE, Milhous WK, Solaja BA (2000) Cholic acid derivatives as 1,2,4,5-tetraoxane carriers: structure and antimalarial and antiproliferative activity. J Med Chem 43:3274–3282 doi:10.​1021/​jm000952f PubMedCrossRef
7.
Zurück zum Zitat Bhattacharjee AK, Carvalho KA, Opsenica D, Solaja BA (2005) Structure–activity relationship study of steroidal 1,2,4,5-tetraoxane animalarials using computational procedures. J Serb Chem Soc 70:329–345 doi:10.2298/JSC0503329B CrossRef Bhattacharjee AK, Carvalho KA, Opsenica D, Solaja BA (2005) Structure–activity relationship study of steroidal 1,2,4,5-tetraoxane animalarials using computational procedures. J Serb Chem Soc 70:329–345 doi:10.​2298/​JSC0503329B CrossRef
8.
Zurück zum Zitat Doorenbos HE, Decker DL (1973) Antimalarial Synthesis, Annual Technical Report No. Am-1A-73. The Dow Chemical Company Doorenbos HE, Decker DL (1973) Antimalarial Synthesis, Annual Technical Report No. Am-1A-73. The Dow Chemical Company
9.
Zurück zum Zitat Opsenica I, Terzic N, Opsenica D, Angelovski G, Lehnig M, Eilbracht P, Tinant B, Juranic Z, Smith KS, Yang YS, Diaz DS, Smith PL, Milhous WK, Dokovic D, Solaja BA (2006) Tetraoxane antimalarials and their reaction with Fe(II). J Med Chem 49:3790–3799 doi:10.1021/jm050966r PubMedCrossRef Opsenica I, Terzic N, Opsenica D, Angelovski G, Lehnig M, Eilbracht P, Tinant B, Juranic Z, Smith KS, Yang YS, Diaz DS, Smith PL, Milhous WK, Dokovic D, Solaja BA (2006) Tetraoxane antimalarials and their reaction with Fe(II). J Med Chem 49:3790–3799 doi:10.​1021/​jm050966r PubMedCrossRef
10.
Zurück zum Zitat Amewu R, Stachulski AV, Ward SA, Berry NG, Bray PG, Davies J, Labat G, Vivas L, O’Neill PM (2006) Design and synthesis of orally active dispiro 1,2,4,5-tetraoxanes; synthetic antimalarials with superior activity to artemisinin. Org Biomol Chem 4:4431–4436 doi:10.1039/b613565j PubMedCrossRef Amewu R, Stachulski AV, Ward SA, Berry NG, Bray PG, Davies J, Labat G, Vivas L, O’Neill PM (2006) Design and synthesis of orally active dispiro 1,2,4,5-tetraoxanes; synthetic antimalarials with superior activity to artemisinin. Org Biomol Chem 4:4431–4436 doi:10.​1039/​b613565j PubMedCrossRef
11.
Zurück zum Zitat Woerdenbag HJ, Moskal TA, Pras N, Malingré TM, el-Feraly FS, Kampinga HH, Konings AW (1993) Cytotoxicity of artemisinin-related endoperoxides to Ehrlich ascites tumor cells. J Nat Prod 56:849–856 doi:10.1021/np50096a007 PubMedCrossRef Woerdenbag HJ, Moskal TA, Pras N, Malingré TM, el-Feraly FS, Kampinga HH, Konings AW (1993) Cytotoxicity of artemisinin-related endoperoxides to Ehrlich ascites tumor cells. J Nat Prod 56:849–856 doi:10.​1021/​np50096a007 PubMedCrossRef
12.
Zurück zum Zitat Efferth T, Rücker G, Falkenberg M, Manns D, Olbrich A, Fabry U, Osieka R (1996) Detection of apoptosis in KG-1a leukemic cells treated with investigational drugs. Arzneimittelforschung 46:196–200PubMed Efferth T, Rücker G, Falkenberg M, Manns D, Olbrich A, Fabry U, Osieka R (1996) Detection of apoptosis in KG-1a leukemic cells treated with investigational drugs. Arzneimittelforschung 46:196–200PubMed
14.
Zurück zum Zitat Solaja BA, Terzic N, Pocsfalvi G, Gerena L, Tinant B, Opsenica D, Milhous WK (2002) Mixed steroidal 1,2,4,5-tetraoxanes: antimalarial and antimycobacterial activity. J Med Chem 45:3331–3336 doi:10.1021/jm020891g PubMedCrossRef Solaja BA, Terzic N, Pocsfalvi G, Gerena L, Tinant B, Opsenica D, Milhous WK (2002) Mixed steroidal 1,2,4,5-tetraoxanes: antimalarial and antimycobacterial activity. J Med Chem 45:3331–3336 doi:10.​1021/​jm020891g PubMedCrossRef
15.
Zurück zum Zitat Terzic N, Opsenica D, Milic D, Tinant B, Smith KS, Milhous WK, Solaja BA (2007) Deoxycholic acid-derived tetraoxane antimalarials and antiproliferatives(1). J Med Chem 50:5118–5127 doi:10.1021/jm070684m PubMedCrossRef Terzic N, Opsenica D, Milic D, Tinant B, Smith KS, Milhous WK, Solaja BA (2007) Deoxycholic acid-derived tetraoxane antimalarials and antiproliferatives(1). J Med Chem 50:5118–5127 doi:10.​1021/​jm070684m PubMedCrossRef
18.
Zurück zum Zitat Martin SJ, Lennon SV, Bonham AM, Cotter TG (1990) Induction of apoptosis (programmed cell death) in human leukemic HL-60 cells by inhibition of RNA or protein synthesis. J Immunol 145:1859–1867PubMed Martin SJ, Lennon SV, Bonham AM, Cotter TG (1990) Induction of apoptosis (programmed cell death) in human leukemic HL-60 cells by inhibition of RNA or protein synthesis. J Immunol 145:1859–1867PubMed
22.
Zurück zum Zitat Eckstein-Ludwig U, Webb RJ, Van Goethem ID, East JM, Lee AG, Kimura M, O’Neill PM, Bray PG, Ward SA, Krishna S (2003) Artemisinins target the SERCA of Plasmodium falciparum. Nature 424:957–961 doi:10.1038/nature01813 PubMedCrossRef Eckstein-Ludwig U, Webb RJ, Van Goethem ID, East JM, Lee AG, Kimura M, O’Neill PM, Bray PG, Ward SA, Krishna S (2003) Artemisinins target the SERCA of Plasmodium falciparum. Nature 424:957–961 doi:10.​1038/​nature01813 PubMedCrossRef
24.
Zurück zum Zitat Shterman N, Kupfer B, Moroz C (1991) Comparison of transferrin receptors, iron content and isoferritin profile in normal and malignant human breast cell lines. Pathobiology 59:19–25 doi:10.1159/000163611 PubMedCrossRef Shterman N, Kupfer B, Moroz C (1991) Comparison of transferrin receptors, iron content and isoferritin profile in normal and malignant human breast cell lines. Pathobiology 59:19–25 doi:10.​1159/​000163611 PubMedCrossRef
26.
Zurück zum Zitat Collins JA, Schandi CA, Young KK, Vesely J, Willingham MC (1997) Major DNA fragmentation is a late event in apoptosis. J Histochem Cytochem 45:923–934PubMed Collins JA, Schandi CA, Young KK, Vesely J, Willingham MC (1997) Major DNA fragmentation is a late event in apoptosis. J Histochem Cytochem 45:923–934PubMed
Metadaten
Titel
Mixed steroidal tetraoxanes induce apoptotic cell death in tumor cells
verfasst von
Željko Žižak
Zorica Juranić
Dejan Opsenica
Bogdan A. Šolaja
Publikationsdatum
01.10.2009
Verlag
Springer US
Erschienen in
Investigational New Drugs / Ausgabe 5/2009
Print ISSN: 0167-6997
Elektronische ISSN: 1573-0646
DOI
https://doi.org/10.1007/s10637-008-9197-1

Weitere Artikel der Ausgabe 5/2009

Investigational New Drugs 5/2009 Zur Ausgabe

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.